Trial Comparing Infliximab and Infliximab and Azathioprine in the Treatment of Patients With Crohn's Disease na�ve to Both Immunomodulators and Biologic Therapy (Study of Biologic and Immunomodulator Naive Patients in Chrohn's Disease: SONIC
Care Path for the Management of Ulcerative Colitis
|3||Enrolling by invitation||
Enhanced Algorithm for Crohn's Treatment Incorporating Early Combination Therapy
A Prospective Study on the Incidence and Risk Factors Related to Infection in Patients With Inflammatory Bowel Disease
|5||Not yet recruiting||
Reduce Risk for Crohn's Disease Patients
Role of Capsule Endoscopy in the Evaluation of Mucosal Changes During Treatment of Patients With Active Crohn's Disease
Early Serum Infliximab Levels in Severe Ulcerative Colitis.
Study Investigating Tailored Treatment With Infliximab for Active Crohn's Disease
† Study has passed its completion date and status has not been verified in more than two years.